Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isaacs

Showing results (601-610 of 743) with videos related to

Pageof 75
Sort By:
BJU International|October 24, 2013
Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomyJennifer L Beebe-Dimmer, William B Isaacs, Kimberly A Zuhlke, et al.
Rheumatology (Oxford, England)|November 6, 2023
Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacyDaniel Maunder, Philip M Brown, Ben Barron-Millar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 25, 2009
Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11Lingyi Lu, Jielin Sun, Sarah D Isaacs, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2026
Autoreactivity vs autoimmunity: characteristics of autoantigen-specific CD4 T-cells in rheumatoid arthritis and healthJames A Stanway, Daniel Peters, Helen Waller, et al.
Investigational New Drugs|December 14, 2011
Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignanciesGlen J Weiss, Manuel Hidalgo, Mitesh J Borad, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 4, 2009
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infectionMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.
Arthritis Research & Therapy|April 19, 2015
Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trialJoel M Kremer, Alan J Kivitz, Jesus A Simon-Campos, et al.
Human Genetics|June 9, 2004
Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkageJianfeng Xu, Carl D Langefeld, S Lilly Zheng, et al.
Cancer Letters|February 23, 2005
Evidence for a general cancer susceptibility locus at 3p24 in families with hereditary prostate cancerBao-Li Chang, Elizabeth M Gillanders, Sarah D Isaacs, et al.
Cancer Research|November 20, 2002
Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer riskSiqun L Zheng, Bao-li Chang, Dennis A Faith, et al.
Pageof 75

Showing results (601-610 of 743) with videos related to

Sort By:
Pageof 75
BJU International|October 24, 2013
Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomyJennifer L Beebe-Dimmer, William B Isaacs, Kimberly A Zuhlke, et al.
Rheumatology (Oxford, England)|November 6, 2023
Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacyDaniel Maunder, Philip M Brown, Ben Barron-Millar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 25, 2009
Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11Lingyi Lu, Jielin Sun, Sarah D Isaacs, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2026
Autoreactivity vs autoimmunity: characteristics of autoantigen-specific CD4 T-cells in rheumatoid arthritis and healthJames A Stanway, Daniel Peters, Helen Waller, et al.
Investigational New Drugs|December 14, 2011
Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignanciesGlen J Weiss, Manuel Hidalgo, Mitesh J Borad, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 4, 2009
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infectionMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.
Arthritis Research & Therapy|April 19, 2015
Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trialJoel M Kremer, Alan J Kivitz, Jesus A Simon-Campos, et al.
Human Genetics|June 9, 2004
Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkageJianfeng Xu, Carl D Langefeld, S Lilly Zheng, et al.
Cancer Letters|February 23, 2005
Evidence for a general cancer susceptibility locus at 3p24 in families with hereditary prostate cancerBao-Li Chang, Elizabeth M Gillanders, Sarah D Isaacs, et al.
Cancer Research|November 20, 2002
Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer riskSiqun L Zheng, Bao-li Chang, Dennis A Faith, et al.
Pageof 75